ROVAFOVIR ETALAFENAMIDE CITRATE

UNII:	PQY41X26YL
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₁H₂₄FN₆O₆P.C₆H₈O₇
Preferred Substance Name:	ROVAFOVIR ETALAFENAMIDE CITRATE
InChIKey:	UQNIBOGIUNYYCZ-XBRDKGPFSA-N
GSRS Full Record:	PQY41X26YL i

1034559-30-2
Ethyl (2S)-{[(S)-({[(2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl]oxy}methyl)phenoxyphosphonoyl]amino}propanoate, 2-hydroxypropane-1,2,3-tricarboxylate (1:1)
GS-9131 CITRATE
GS9131 CITRATE
L-ALANINE, N-((S)-((((2R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-FLUORO-2,5-DIHYDRO-2-FURANYL)OXY)METHYL)PHENOXYPHOSPHINYL)-, ETHYL ESTER, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
ROVAFOVIR ETALAFENAMIDE CITRATE [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ROVAFOVIR ETALAFENAMIDE CITRATE

Synonyms and Mappings

Resources